DocuSign (DOCU) Suffers a Larger Drop Than the General Market: Key Insights

Thursday, Feb 19, 2026 6:47 pm ET2min read
DOCU--
Aime RobotAime Summary

- DocuSignDOCU-- (DOCU) fell 1.54% to $44.13, underperforming the S&P 500 and tech sector declines.

- Earnings estimates project +10.47% EPS growth and $828.2M revenue, up 6.69% year-over-year.

- Zacks Rank #2 (Buy) reflects stable estimates, with a forward P/E of 10.77 vs. industry 19.62.

- Internet-Software industry ranks 88th (top 36%), leveraging Zacks' proven 2:1 outperformance model.

DocuSign (DOCU) ended the recent trading session at $44.13, demonstrating a -1.54% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 0.28%. Elsewhere, the Dow lost 0.54%, while the tech-heavy Nasdaq lost 0.31%.

Prior to today's trading, shares of the provider of electronic signature technology had lost 20.01% lagged the Computer and Technology sector's loss of 3.36% and the S&P 500's loss of 0.76%.

Market participants will be closely following the financial results of DocuSignDOCU-- in its upcoming release. The company's earnings per share (EPS) are projected to be $0.95, reflecting a 10.47% increase from the same quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $828.2 million, showing a 6.69% escalation compared to the year-ago quarter.

For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of $3.79 per share and a revenue of $3.21 billion, representing changes of +6.76% and +7.86%, respectively, from the prior year.

Investors might also notice recent changes to analyst estimates for DocuSign. These revisions typically reflect the latest short-term business trends, which can change frequently. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.

Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. As of now, DocuSign holds a Zacks Rank of #2 (Buy).

Looking at its valuation, DocuSign is holding a Forward P/E ratio of 10.77. This denotes a discount relative to the industry average Forward P/E of 19.62.

We can additionally observe that DOCUDOCU-- currently boasts a PEG ratio of 0.75. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The average PEG ratio for the Internet - Software industry stood at 1.1 at the close of the market yesterday.

The Internet - Software industry is part of the Computer and Technology sector. Currently, this industry holds a Zacks Industry Rank of 88, positioning it in the top 36% of all 250+ industries.

The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report



Docusign Inc. (DOCU): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Zacks is the leading investment research firm focusing on equities earnings estimates and stock analysis for the individual investor, including stock picks, stock screening, portfolio stock tracker and stock screeners. Copyright 2006-2026 Zacks Equity Research, Inc. editor@zacks.com (Manaing editor) webmaster@zacks.com (Webmaster)

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet